5-Amino-1MQ is a small, non-hormonal molecule that targets lipid metabolism via NNMT inhibition and NAD+ preservation, without affecting appetite
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction
Dose timing, dietary tweaks, and supportive meds can help
This makes the dual-agonist approach a preferred option for those who have struggled with side effects in the past
Understanding these patterns can inform conversations with your provider about when you're likely to reach stable, donation-eligible metabolic parameters